News
In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...
Delaware's top court reversed a ruling that allowed expert testimony in Zantac cancer lawsuits, citing improper legal ...
Delaware's Supreme Court sides with drugmakers including GSK (GSK) and Pfizer (PFE), rejecting expert testimony linking ...
The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a ...
Delaware's highest court ruled on Thursday that nearly 75,000 patients suing four large drugmakers cannot introduce reports ...
Minister confirms no ban on Ranitidine despite NDMA concerns, CDSCO taking measures to ensure patient safety.
India’s Ministry of Health has taken no steps to stop other pharmaceutical companies from continuing to manufacture and sell Ranitidine ...
There is no link between the use of ranitidine, applied for treating and preventing gastric ulcers, and cancer, according to a recent study. Conducted in South Korea, the study, published in the ...
Experts at the US Federal Court state that links between the Ranitidine and cancer (which include lung, liver, and kidney cancer) are illegitimate.
If you are a regular consumer of antacid Ranitidine which is popularly sold as Zantac, you should know that this medicine has been removed by the Indian government in its recent National List of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results